Autres langues Avicanna Inc. OTC Markets

Actions

AVCNF

CA05368K1003

Recherche biotechnologique et médicale

Marché Fermé - OTC Markets 21:36:38 24/08/2026			Varia. 5j.	Varia. 1 janv.
0,0919 ^USD	-5,69%		-3,81%	-43,31%

19/08	Avicanna clôture un placement privé de 500 000 $ CA auprès de l'investisseur pharmaceutique Michael Porter	MT
15/08	Avicanna Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI

Autres langues

19/08	Avicanna Inc. announced that it has received CAD 0.5 million in funding
19/08	Avicanna Closes C$500,000 Private Placement to Pharmaceutical Investor Michael Porter
19/08	Avicanna Announces Closing of Strategic Non-Brokered Private Placement
17/08	Avicanna Reports Q2 2026 Financial Results
15/08	Avicanna Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
15/08	Avicanna Reports Q2 2026 Financial Results
15/08	Avicanna Inc Announces Board Changes
16/07	Avicanna Launching Rapid Onset Medical Cannabis Portfolio in Canada
16/07	Avicanna Introduces Quix Rapid-Onset Medical Cannabis Portfolio
16/07	Avicanna Introduces QUIX™ Rapid-Onset Medical Cannabis Portfolio
30/06	Avicanna Announces Promotion of Nick Hilborn CPA CA to Chief Financial Officer
30/06	Avicanna Inc. Promotes Nick Hilborn to Chief Financial Officer, Effective June 30, 2026
15/06	Avicanna Announces Closing of Non-Brokered Private Placement
14/05	Avicanna Swings to Net Comprehensive Loss in Q1
14/05	Earnings Flash (AVCN.TO) Avicanna Reports Q1 Revenue $6.7M, Up 6% YoY and Highest Ever
14/05	Avicanna Reports Q1 2026 Financial Statements
13/05	Avicanna Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
08/05	Avicanna Announces Results of Annual General and Special Meeting
02/05	Avicanna Announces Change in Board of Directors
02/05	Avicanna Inc. Announces Resignation of Eileen McCormack as A Member of the Board of Directors , Effective May 1, 2026
30/04	Companies with cannabis-based drugs eye IPOs, private funding boost after US reclassification
28/04	Avicanna Welcomes Initial U.S. Rescheduling of Medical Cannabis & Provides Scientific Update
23/04	Instant View: Cannabis rescheduling fuels optimism across industry
21/04	Annual General and Special Meeting of Shareholders to be held May 7, 2026
20/04	Avicanna Announces Agenda for 6th Annual Clinical Symposium on Cannabinoid Therapeutics